We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

39 hedge funds and large institutions have $5.79M invested in Perspective Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 10

0.11% less ownership

Funds ownership: 1.23% → 1.12% (-0.11%)

13% less funds holding

Funds holding: 45 → 39 (-6)

15% less capital invested

Capital invested by funds: $6.78M → $5.79M (-$993K)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
39
Holders Change
-6
Holders Change %
-13.33%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
10
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TMWM
Taylor & Morgan Wealth Management
Michigan
+$76.6K
2
Citadel Advisors
Citadel Advisors
Florida
+$46.3K
3
BA
Bard Associates
Illinois
+$18.2K
4
State Street
State Street
Massachusetts
+$12.6K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$9.55K

Top Sellers

Rank Fund Capital Flow
1
HPWM
Highland Private Wealth Management
Washington
-$377K
2
Renaissance Technologies
Renaissance Technologies
New York
-$206K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$53.6K
4
UBS Group
UBS Group
Switzerland
-$44.2K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$24K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.2M -$6.7K -1,837 -0.3%
PCM
2
Perkins Capital Management
Minnesota
$1.02M -$912 -250 -0.1%
BlackRock
3
BlackRock
New York
$885K +$346 +95 +0%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$406K – – –
BA
5
Bard Associates
Illinois
$243K +$18.2K +5,000 +8%
State Street
6
State Street
Massachusetts
$201K +$12.6K +3,458 +7%
TMWM
7
Taylor & Morgan Wealth Management
Michigan
$200K +$76.6K +21,000 +62%
Renaissance Technologies
8
Renaissance Technologies
New York
$151K -$206K -56,359 -57%
Northern Trust
9
Northern Trust
Illinois
$95K – – –
BCM
10
Bridgeway Capital Management
Texas
$67K – – –
Creative Planning
11
Creative Planning
Kansas
$47K +$5.47K +1,500 +13%
Citadel Advisors
12
Citadel Advisors
Florida
$46K +$46.3K +12,694 New
Morgan Stanley
13
Morgan Stanley
New York
$33K +$5.25K +1,440 +19%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$28K -$8.02K -2,200 -22%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$24K +$9.55K +2,620 +66%
CAG
16
Crestwood Advisors Group
Massachusetts
$20K – – –
Cerity Partners
17
Cerity Partners
New York
$15K – – –
Millennium Management
18
Millennium Management
New York
$14K +$6.09K +1,669 +78%
BBNA
19
Bremer Bank National Association
Minnesota
$11K – – –
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$9K -$204 -56 -2%
Commonwealth Equity Services
21
Commonwealth Equity Services
Massachusetts
$9K – – –
BIM
22
Bullseye Investment Management
Ohio
$9K +$9.12K +2,500 New
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$7K -$53.6K -14,689 -89%
Ameriprise
24
Ameriprise
Minnesota
$7K – – –
TWM
25
TMD Wealth Management
Arizona
$7K – – –
1
2

CATX Hedge Fund Activity: Q1 2022 in Review

39 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2022, worth a combined $5.79M — down 15% from $6.78M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of CATX and 3 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 10 added.

The largest buyer was Taylor & Morgan Wealth Management, adding an estimated $76.6K. The largest seller was Highland Private Wealth Management, exiting entirely with an estimated $377K sold.

  • 39 institutional investors held Perspective Therapeutics (CATX) as of Q1 2022, down from 45 in Q4 2021.
  • Funds reported $5.79M of Perspective Therapeutics stock for Q1 2022, down 15% quarter-over-quarter.
  • 3 funds opened new Perspective Therapeutics positions in Q1 2022 and 9 closed out, a net change of -6 holders.
  • The largest Perspective Therapeutics buyer in Q1 2022 was Taylor & Morgan Wealth Management, an estimated $76.6K added.
  • The largest Perspective Therapeutics seller in Q1 2022 was Highland Private Wealth Management, an estimated $377K sold.

Based on aggregated 13F filings for Q1 2022.